Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance.
Chandra A, Jahangiri A, Chen W, Nguyen AT, Yagnik G, Pereira MP, Jain S, Garcia JH, Shah SS, Wadhwa H, Joshi RS, Weiss J, Wolf KJ, Lin JG, Müller S, Rick JW, Diaz AA, Gilbert LA, Kumar S, Aghi MK.
Chandra A, et al. Among authors: kumar s.
Cancer Res. 2020 Apr 1;80(7):1498-1511. doi: 10.1158/0008-5472.CAN-19-1305. Epub 2020 Feb 10.
Cancer Res. 2020.
PMID: 32041837
Free PMC article.